Analysis of three variables in sampling solutions used to assay bacteria of hands: type of solution, use of antiseptic neutralizers, and solution temperature.

Journal of Clinical Microbiology
E L LarsonC A Evans

Abstract

Tests were performed using the sterile bag technique to determine the effects of type of sampling solution, use of antiseptic neutralizers, and solution temperature on the detection and quantitation of bacteria on hands. Using paired hand cultures, three sampling solutions were compared: quarter-strength Ringer solution, a phosphate buffer containing Triton X-100, and the same buffer containing antiseptic neutralizers. The phosphate buffer containing Triton X-100 was significantly better than quarter-strength Ringer solution in mean bacterial yield; the neutralizer-containing sampling solution was slightly better than Triton X-100-containing solution, although differences were not significant at the P = 0.05 level. Temperature (6 or 23 degrees C) of the sampling solution showed no consistent effect on bacterial yield from hands tested with the fluid containing neutralizers.

Citations

Aug 1, 1982·The Journal of Hygiene·B G Adams, T J Marrie
Jun 5, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D L PatersonR R Muder
Jun 14, 2006·Journal of Advanced Nursing·Hsiu-Fang HsiehFeng-Ping Lee
Nov 26, 2016·Microorganisms·Frank VriesekoopCryn Russell
Jul 25, 2018·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Aline WolfensbergerHugo Sax
Aug 1, 1982·The Journal of Hygiene·B G Adams, T J Marrie
May 1, 1988·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·W A HornJ J Leyden
Sep 11, 2007·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Mette FagernesPer Bjark
May 3, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Mary K HaydenRobert A Weinstein
Jan 14, 2011·The Journal of International Medical Research·F EksiN Aydin
Oct 15, 2013·Applied and Environmental Microbiology·Pengbo LiuChristine L Moe
Sep 4, 2015·Journal of the Pediatric Infectious Diseases Society·Yu-hui FerngLisa Saiman
Jan 25, 2019·The American Journal of Tropical Medicine and Hygiene·Tarique Md Nurul HudaAdam Biran
Jun 1, 1997·AORN Journal·S M Wheelock, S Lookinland
May 3, 2007·Mycoses·Mustafa YildirimSelma Cakir
Jun 24, 2014·Scandinavian Journal of Infectious Diseases·Mustafa YildirimCigdem Ozaydin
Mar 7, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·A R TenorioR A Weinstein
Jul 10, 2001·Veterinary Surgery : VS·G E HennigC A Kirker-Head
Oct 22, 2016·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Mirian de Freitas DalBenAnna Sara Levin
Jan 8, 2005·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Anne ZawackiDonald Goldmann
Jan 9, 2008·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Mary K HaydenRobert A Weinstein
May 1, 1988·Journal of Clinical Microbiology·K J McGinleyJ J Leyden
Dec 1, 1985·Antimicrobial Agents and Chemotherapy·D M Sedlock, D M Bailey
Nov 17, 2019·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·M Puig-AsensioE N Perencevich
Oct 1, 1986·Antimicrobial Agents and Chemotherapy·E L LarsonB E Laughon
May 6, 2021·International Journal of Clinical Practice·Bock-Hui YounMyung-Haeng Hur
Oct 1, 1987·Antimicrobial Agents and Chemotherapy·E L Larson, B E Laughon
Mar 1, 1986·Journal of Clinical Microbiology·E L LarsonJ J Leyden
Sep 1, 1994·Journal of Clinical Microbiology·L J StrausbaughR Tjoelker
Feb 1, 1996·Journal of Clinical Microbiology·L J StrausbaughM A Pfaller
Oct 8, 1981·American Journal of Infection Control·E L Larson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.